Back to Courses and Symposia

The inaugural ISB Virtual Microbiome Series highlighted recent in silico, in vitro, and in vivo advances toward engineering the gut microbiome to resolve complex diseases.

We hosted the 2020 ISB Virtual Microbiome Series consisting of a one-day virtual course and a one-day symposium examining the latest cutting-edge microbiome research. 

This was the inaugural microbiome series of its kind and was geared toward graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious people from across the globe. 

The event was recorded. Scroll down to see the full collection of videos.

Series background

When a new scientific discipline is born, there is an initial natural history phase, where explorers map out the contours of the unknown. For the past couple of decades, we have characterized the form and function of microbial ecosystems in and on the human body. 

Now, with this wealth of information collected on the human microbiome serving as a foundation, we have entered into a new phase of testing targeted, mechanistic hypotheses for how our microbiota contribute to the etiologies of diseases. 

ISB hosted a series of events in October of 2020 that highlighted recent in silico, in vitro, and in vivo advances toward engineering the gut microbiome to resolve complex diseases.

Virtual Microbiome Course 

Dr. Sean Gibbons delivers opening remarks.
Dr. Christian Diener: “Analyzing amplicon sequencing data with Qiime 2 – Part 1”
Dr. Christian Diener: “Analyzing amplicon sequencing data with Qiime 2 – Part 2”
Dr. Christian Diener: “Modeling microbiota-wide metabolism with MICOM – Part 1”
Dr. Christian Diener: “Modeling microbiota-wide metabolism with MICOM – Part 2”
Presentation by Drs. Tomasz Wilmanski and Noa Rappaport 
Closing remarks

Virtual Microbiome Symposium

Welcoming remarks by Dr. Sean Gibbons

Session 1: Mechanistic Models

Dr. Jason Papin: “Metabolic mechanisms of interaction in microbial communities”
Dr. Ines Thiele: “Large-scale modelling of the human microbiome accounts for strain-specific drug metabolism”
Dr. Priyanka Baloni moderates a panel discussion from session 1.

Session 2: In Vitro Approaches

Dr. Thomas Gurry: “Exploiting in vitro measurements of gut microbial fermentation capability towards disease prevention”
Dr. Julie McDonald: “Using artificial gut models to study how the gut microbiota protects against intestinal infections”
Dr. Noa Rappaport moderates a panel discussion from session 2.

Session 3: In Vivo Interventions

Dr. Gautam Dantas: “Predicting and Combating Pathogenic and Abiotic Disruptions to Diverse Microbiomes”
Dr. Johanna Lampe: “Diet-Gut Microbiome Interactions: Controlled Feeding Studies and Metabolic Phenotypes”
Dr. Tomasz Wilmanski moderates a panel discussion from session 3.
Dr. Sean Gibbons delivers closing remarks.